Try our Advanced Search for more refined results
September 30, 2019
SALIX PHARMACEUTICALS, LTD. et al v. SANDOZ INC.
Case Number:
2:19-cv-18566
Court:
Nature of Suit:
835(Patent - Abbreviated New Drug Application(ANDA))
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 01, 2019
Sandoz Hit With Patent Suit Over Bausch's IBS Drug Xifaxan
Bausch Health and its gastrointestinal medicine subsidiary said Tuesday that they sued Novartis unit Sandoz Inc. for allegedly infringing 14 patents for the irritable bowel syndrome drug Xifaxan.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login